The Effect of Topical Aminophylline on Hyposmia and Anosmia

Document Type : Original


Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Iran University of Medical Science, Tehran, Iran.


Olfactory training is accounted as a significantly beneficial therapy for hyposmia or anosmia. There is some evidence about methylxanthine usage for this issue. In the present study, we have investigated the effects of topical aminophylline in hyposmic and anosmic patients.
Materials and Methods:
In this clinical trial study, patients were randomly divided into two groups (n= 20/each), the case group was given aminophylline drops over a three-month period (using the contents of the vial aminophylline in the form of nasal drops, 250 micrograms daily) with olfactory training and the control group was given normal saline drops with olfactory training over a three-month period. The olfactory capacities were assessed before the start and after the completion of treatments using a valid and reliable smell identification test.
In the saline and aminophylline groups, the mean ± SD relative changes in SIT score were 0.55±0.31 and 0.85±0.56, respectively. As a result, the SIT score in the saline group climbed by 55 percent but increased by 85 percent in the aminophylline group. The difference in SIT score between pre- and post-test was meaningful in both groups (P< 0.001). The aminophylline group scored significantly higher according to the marginal longitudinal regression model, adjusting baseline parameters.
Intranasal aminophylline plus olfactory training significantly improved SIT scores in severe hyposmia or anosmia. Hypothetically, these effects are mediated through changes in cAMP and cGMP.


  1. Gorzkowski V, Bevilacqua S, Charmillon A, Jankowski R, Gallet P, Rumeau C, Nguyen DT. Evolution of olfactory disorders in COVID‐19 patients. The Laryngoscope. 2020;130(11):2667-73.
  2. Kamrava SK, Tavakol Z, Talebi A, Farhadi M, Jalessi M, Hosseini SF, Amini E, Chen B, Hummel T, Alizadeh R. A study of depression, partnership and sexual satisfaction in patients with post-traumatic olfactory disorders. Scientific Reports. 2021;11(1):1-8.
  3. Yang J, Pinto JM. The epidemiology of olfactory disorders. Current otorhinolaryngology reports. 2016;4(2):130-41.
  4. Kang JW, Lee YC, Han K, Kim SW, Lee KH. Epidemiology of anosmia in South Korea: a nationwide population-based study. Scientific Reports. 2020;10(1):1-8.
  5. Hinz A, Luck T, Riedel-Heller SG, Herzberg PY, Rolffs C, Wirkner K, et al. Olfactory dysfunction: properties of the Sniffin’Sticks Screening 12 test and associations with quality of life. European Archives of Oto-Rhino-Laryngology. 2019;276(2):389-95.
  6. Otte MS, Eckel HN, Poluschkin L, Klussmann JP, Luers JC. Olfactory dysfunction in patients after recovering from COVID-19. Acta Oto-Laryngologica. 2020;140(12):1032-5.
  7. Daneshfar M, Dadashzadeh N, Ahmadpour M, Ragati Haghi H, Rahmani V, Frouzesh M, et al. Lessons of mortality following COVID-19 epidemic in the United States especially in the geriatrics. J Nephropharmacol. 2021;10(1):e06-e.
  8. Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection. 2020;13(4):e102899.
  9. Panaliappan TK, Wittmann W, Jidigam VK, Mercurio S, Bertolini JA, Sghari S, Bose R, Patthey C, Nicolis SK, Gunhaga L. Sox2 is required for olfactory pit formation and olfactory neurogenesis through BMP restriction and Hes5 upregulation. Development. 2018;145(2):dev153791.
  10. Durante MA, Kurtenbach S, Sargi ZB, Harbour JW, Choi R, Kurtenbach S, Goss GM, Matsunami H, Goldstein BJ. Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nature neuroscience. 2020;23(3):323-6.
  11. Kattar N, Do TM, Unis GD, Migneron MR, Thomas AJ, McCoul ED. Olfactory training for postviral olfactory dysfunction: systematic review and meta-analysis. Otolaryngology–Head and Neck Surgery. 2021;164(2):244-54.
  12. Henkin R, Abdelmeguid M. Agnostic Pathology of Molecular Biomarkers in Smell Loss (Hyposmia). The FASEB Journal. 2018;32(S1):818-16.
  13. Neta FI, Fernandes AC, Vale AJ, Pinheiro FI, Cobucci RN, de Azevedo EP, Guzen FP. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Current Research in Pharmacology and Drug Discovery. 2021;2:100035.
  14. Neame M, Aragon O, Fernandes RM, Sinha I. Salbutamol or aminophylline for acute severe asthma: how to choose which one, when and why? Archives of Disease in Childhood-Education and Practice. 2015;100(4):215-22.
  15. Doukky R, Demori RM, Jain S, Kiriakos R, Mwansa V, Calvin JE. Attenuation of the side effect profile of regadenoson: A randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging.“The ASSUAGE trial”. Journal of Nuclear Cardiology. 2012;19(3):448-57.
  16. Stirt JA, Sullivan SF. Aminophylline. Anesthesia & Analgesia. 1981;60(8):587-602.
  17. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr; 31(2):180-91.
  18. Taherkhani S, Moztarzadeh F, Mehdizadeh Seraj J, Hashemi Nazari SS, Taherkhani F, Gharehdaghi J, Okazi A, Pouraghaei S. Iran smell identification test (Iran-SIT): A modified version of the university of pennsylvania smell identification test (UPSIT) for Iranian population. Chemosensory perception. 2015;8(4):183-91.
  19. Kamrava SK, Jalessi M, Ghalehbaghi S, Amini E, Alizadeh R, Rafiei F, Moosa S, Farhadi M. Validity and reliability of Persian smell identification test. Iranian Journal of Otorhinolaryngology. 2020;32(109):65-71.
  20. Dibattista M, Reisert J. The odorant receptor-dependent role of olfactory marker protein in olfactory receptor neurons. Journal of Neuroscience. 2016;36(10):2995-3006.
  21. Gudziol V, Pietsch J, Witt M, Hummel T. Theophylline induces changes in the electro-olfactogram of the mouse. European archives of oto-rhino-laryngology. 2010;267(2):239-43.
  22. Lee JJ, Peterson AM, Kallogjeri D, Jiramongkolchai P, Kukuljan S, Schneider JS, Klatt-Cromwell CN, Drescher AJ, Brunworth JD, Piccirillo JF. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction. American journal of otolaryngology. 2022; 43(2):103299.
  23. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Archives of Otolaryngology–Head & Neck Surgery. 2012; 138(11): 1064-70.
  24. Hosein W, Henkin RI. Therapeutic diminution of Interleukin-10 with intranasal theophylline administration in hyposmic patients. American Journal of Otolaryngology. 2022;43(2):103375.
  25. Barzegar A, Ghadipasha M, Rezaei N, Forouzesh M, Valizadeh R. New hope for treatment of respiratory involvement following COVID-19 by bromhexine. J Nephropharmacol. 2021;10(2):e11-e.
  26. Tabatabaii SA, Soltani P, Khanbabaee G, Sharma D, Valizadeh R, Farahbakhsh N, et al. SARS Coronavirus 2, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome in Children: A Review on Epidemiology, Clinical Presentation, and Diagnosis. 2020;8(4):e104860.
  27. Besharat S AN, Dadashzadeh N, Talaie R, Mousavi SS, Barzegar A, Tavana S, Valizadeh R, Frouzesh M.. Clinical and Demographic Characteristics of Patients with COVID-19 Who Died in Modarres Hospital. Open Access Maced J Med Sci 2020; 8(T1):144-9.
  28. Qiao X-F, Wang G-P, Li X, Bai Y-H, Zheng W. Analysis of the clinical effect of olfactory training on olfactory dysfunction after upper respiratory tract infection. Acta oto-laryngologica. 2019; 139(7):


  1. Endiyarti F, Prawiroharjo P. The Effectiveness of Olfactory Training in Elderly with Anosmia Evidence Base Case Report. Advanced Science Letters. 2018; 24(9):6941-4.
  2. Mahmut MK, Musch M, Han P, Abolmaali N, Hummel T. The effect of olfactory training on olfactory bulb volumes in patients with idiopathic olfactory loss. Rhinology. 2020;58(4):410-2.